Related Experiment Video
Updated: Nov 24, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Modification of the left atrial appendage and its role in stroke risk reduction with non-valvular atrial fibrillation
Hashrul N Rashid1,2, Jamie Layland2,3
1Monash Cardiovascular Research Centre, Monash University, Melbourne, Australia.
Insights
Atrial fibrillation patients at risk of stroke can benefit from left atrial appendage exclusion. This procedure may reduce embolic events and potentially allow omission of anticoagulation therapy in select individuals.
Area of Science:
- Cardiology
- Vascular Surgery
- Neurology
Background:
- Atrial fibrillation is a prevalent cardiovascular disorder.
- Patients face risks of cerebrovascular and systemic embolic events.
- Anticoagulation therapy is standard but carries bleeding risks for some.
Purpose of the Study:
- To review the role of the left atrial appendage in embolic events.
- To summarize current evidence on left atrial appendage modification.
- To discuss future trials impacting procedural practices.
Main Methods:
- Literature review of atrial fibrillation, embolic events, and left atrial appendage.
- Analysis of current evidence on surgical and percutaneous left atrial appendage exclusion.
- Examination of ongoing and planned clinical trials.
Main Results:
- The left atrial appendage is a primary site for thrombus formation in atrial fibrillation.
- Left atrial appendage exclusion aims to reduce embolic risk.
- Procedures may enable anticoagulation minimization or omission.
Conclusions:
- Left atrial appendage exclusion is a strategy for stroke risk reduction in atrial fibrillation.
- Further evidence from trials will refine patient selection and procedural indications.
- This approach offers an alternative for patients unsuitable for long-term anticoagulation.
Abstract:
Atrial fibrillation is one of the most common cardiovascular disorders encountered by clinicians in clinical practice. Patients with atrial fibrillation are at risk of cerebrovascular and systemic embolic events, which may be attenuated by commencement of anticoagulation therapy. Even so, due to extremely high bleeding risk certain patients may not be suitable for long-term anticoagulation therapy. The left atrial appendage is a common site for thrombus formation in patients with atrial fibrillation. Left atrial appendage exclusion, either surgical or percutaneous, has been performed to ostensibly reduce the risk of cerebrovascular events and potentially minimise or omit anticoagulation therapy in select patients. This review summarises the role of the left atrial appendage in cerebrovascular events, current evidence with modification of the left atrial appendage and future trials that may change practice with these procedures.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management

